Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Favrille Falls On Interim Analysis Of Pivotal FavId Study In NHL

Nov. 14, 2006

By Jennifer Boggs

Favrille Falls On Interim Analysis Of Pivotal FavId Study In NHL

Nov. 14, 2006

By Jennifer Boggs

Optimer Files For $86M IPO To Fund Anti-Infective Work

Nov. 13, 2006

By Jennifer Boggs

Optimer Files For $86M IPO To Fund Anti-Infective Work

Nov. 13, 2006

By Jennifer Boggs

Osiris' Adult Stem Cell Product Shows Promise In GVHD Trial

Nov. 10, 2006

By Jennifer Boggs

Solstice Adds $85M Through Series B Round And Debt Deal

Nov. 9, 2006

By Jennifer Boggs

Solstice Adds $85M Through Series B Round And Debt Deal

Nov. 9, 2006

By Jennifer Boggs

Cytogen Bringing In $20M For Product Launch, Clinical Work

Nov. 8, 2006

By Jennifer Boggs

Cytogen Bringing In $20M For Product Launch, Clinical Work

Nov. 8, 2006

By Jennifer Boggs

Ambit, Cephalon Enter Potential $250M Deal On Kinase Inhibitors

Nov. 7, 2006

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...